Lyell Immunopharma, Inc. (LYEL) Net income 2019–2025
Lyell Immunopharma, Inc. (LYEL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$274.4MFY2025 · since FY2019: -$129.4M → -$274.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$274.4M | +20.0% |
| FY2024 | -$343.0M | -46.2% |
| FY2023 | -$234.6M | -28.1% |
| FY2022 | -$183.1M | +26.8% |
| FY2021 | -$250.2M | -22.4% |
| FY2020 | -$204.5M | -58.0% |
| FY2019 | -$129.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice